Certificate of Analysis
GLP-3 R-CAGRI-6-2-26-COA
GLP-3 R-CAGRI-6-2-26-COA
GLP-3 R/ CAGRI 12.5/2.5 MG
GLP-3 R/ CAGRI 12.5/2.5 MG - Image 2

1993 in stock

Quantity Price / Per Vial
1 – 3 $200.00
4 – 7 $180.00
8+ $160.00

GLP-3 R/ CAGRI 12.5/2.5 MG

$200.00

Incretin & Amylin Research Blend (GLP-3 R/CAGRI) — 12.5/2.5 MG

Key Features
  • Dual-component research blend for incretin and amylin pathway studies
  • Lyophilized for stability and precise laboratory handling
  • Analytical QC confirms purity and batch consistency

Description

========================
GLP-3 R/CAGRI — Incretin & Amylin Analog Research Blend
========================

Class: Dual-component research blend; GLP-3 R/ related incretin pathway analog and Cagri-related amylin analog for metabolic signaling research

Research Focus (non-clinical):

  • GLP-1, GIP, glucagon, and amylin receptor pathway signaling studies
  • Metabolic-response marker analysis in preclinical research models
  • Cellular signaling investigations involving incretin and amylin-associated pathways
  • Energy-balance, receptor-activation, and downstream pathway readout studies
  • Comparative research involving multi-pathway peptide blend behavior

Notes for Investigators:
Frequently referenced for non-clinical research involving combined incretin and amylin pathway analysis, receptor-signaling panels, and metabolic research model investigations.

Regulatory & Use

  • Research-only material. Not for human or veterinary use.
  • No clinical claims; no usage guidance provided.
Description

Description

========================
GLP-3 R/CAGRI — Incretin & Amylin Analog Research Blend
========================

Class: Dual-component research blend; GLP-3 R/ related incretin pathway analog and Cagri-related amylin analog for metabolic signaling research

Research Focus (non-clinical):

  • GLP-1, GIP, glucagon, and amylin receptor pathway signaling studies
  • Metabolic-response marker analysis in preclinical research models
  • Cellular signaling investigations involving incretin and amylin-associated pathways
  • Energy-balance, receptor-activation, and downstream pathway readout studies
  • Comparative research involving multi-pathway peptide blend behavior

Notes for Investigators:
Frequently referenced for non-clinical research involving combined incretin and amylin pathway analysis, receptor-signaling panels, and metabolic research model investigations.

Regulatory & Use

  • Research-only material. Not for human or veterinary use.
  • No clinical claims; no usage guidance provided.

Related products